Galactomannan detection for invasive aspergillosis in immunocompromised patients

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 9, 2015, Pages

  Leeflang, Mariska M G ^a   Debets Ossenkopp, Yvette J ^b   Wang, Junfeng ^c   Visser, Caroline E ^c   Scholten, Rob J P M ^d   Hooft, Lotty ^d   Bijlmer, Henk A ^e   Reitsma, Johannes B ^d   Zhang, Mingming ^f   Bossuyt, Patrick M M ^a   Vandenbroucke Grauls, Christina M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MEDICAL CENTER HAAGLANDEN   (Netherlands)

^f SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOMANNAN; BIOLOGICAL MARKER; MANNAN;

ANTIFUNGAL THERAPY; BLOOD LEVEL; CARBOHYDRATE ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG USE; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INVASIVE ASPERGILLOSIS; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ASPERGILLOSIS; BLOOD; IMMUNOLOGY; META ANALYSIS; OPPORTUNISTIC INFECTIONS;

ASPERGILLOSIS; BIOMARKERS; HUMANS; IMMUNOCOMPROMISED HOST; MANNANS; OPPORTUNISTIC INFECTIONS; SENSITIVITY AND SPECIFICITY;

EID: 84965190913     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007394.pub2     Document Type: Review

References (136)

1. Acosta J, Catalan M, Del Palacio-Perez-Medel A, Montejo J-C, Cruz-Bertolo J, Moragues MD, et al. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1, 3)-beta-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. European Journal of Clinical Microbiology and Infectious Diseases 2012;31(5):721-31. 3248591
2. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clinical Infectious Diseases 2004;38(6):917-20. 3248593
3. Allan EK, Jordanides NE, McLintock LA, Copland M, Devaney M, Stewart K, et al. Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection. British Journal of Haematology 2005;128(4):578-9. 3248595
4. Badiee P, Alborzi A, Karimi M, Pourabbas B, Haddadi P, Mardaneh J, et al. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. Journal of Infection in Developing Countries 2012;6(4):352-7. [PUBMED: 22505446]3248597
5. Barnes RA, Stocking K, Bowden S, Poynton MH, White PL. Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway. Journal of Infection 2013;67(3):206-14. 3248599
6. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. British Journal of Haematology 2003;121(3):448-57. 3248601
7. Bialek R, Moshous D, Casanova JL, Blanche S, Hennequin C. Aspergillus antigen and PCR assays in bone marrow transplanted children. European Journal of Medical Research 2002;7(4):177-80. 3248603
8. Bretagne S, Costa JM, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clinical Infectious Diseases 1998;26(6):1407-12. 3248605
9. Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. British Journal Haematology 2004;125(2):196-202. 3248607
10. Busca A, Locatelli F, Barbui A, Limerutti G, Serra R, Libertucci D, et al. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation. Transplantation Proceedings 2006;38(5):1610-3. 3248609
11. da Silva RL, Ribeiro P, Abreu N, Ferreira T, Fernandes T, Monteiro A, et al. Early diagnosis of invasive aspergillosis in neutropenic patients. comparison between serum galactomannan and polymerase chain reaction. Clinical Medicine Insights: Oncology 2010;4:81-8. 3248611
12. De Mol M, De Jongste JC, Van Westreenen M, Merkus PJFM, De Vries AHC, Hop WCJ, et al. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatric Pulmonology 2013;48(8):789-96. 3248613
13. Doermann F, Accoceberry I, Weill FX, Agape P, Boiron JM, Marit G, et al. Evaluation of Aspergillus antigen detection in sera by ELISA for diagnosis of invasive aspergillosis in a hematological unit. Journal de Mycologie Medicale 2002;12(3):131-5. 3248615
14. Florent M, Katsahian S, Vekhoff A, Levy V, Rio B, Marie JP, et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. Journal of Infectious Diseases 2006;193(5):741-7. 3248617
15. Foy PC, van Burik JA, Weisdorf DJ. Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2007;13(4):440-3. 3248619
16. Gao X, Chen L, Hu G, Mei H. Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests. Annals of Saudi Medicine 2010;30(3):193-7. 3248621
17. Ghosh I, Raina V, Kumar L, Sharma A, Bakhshi S, Iqbal S. Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation. Indian Journal of Medical and Paediatric Oncology 2013;34(2):74-9. 3248623
18. He H, Ding L, Chang S, Li F, Zhan Q. Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease. Medical Mycology 2011;49(4):345-51. 3248625
19. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. Journal of Clinical Oncology 2002;20(7):1898-906. 3248627
20. Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatric Blood and Cancer 2007;48(1):28-34. 3248629
21. Jha AK, Bansal D, Chakrabarti A, Shivaprakash MR, Trehan A, Marwaha RK. Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies. Mycoses 2013;56(4):442-8. 3248631
22. Kallel K, Ladeb S, Belhadj S, Jerbi A, Ben Othman T, Abdelkefi A, et al. Evaluation of aspergillary antigenemia for monitoring neutropenic patients. Journal de Mycologie Medicale 2003;13(4):199-202. 3248633
23. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. Journal of Clinical Microbiology 2004;42(6):2733-41. 3248635
24. Ku NS, Han SH, Choi JY, Kim SB, Kim H-W, Jeong SJ, et al. Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients. Scandinavian Journal of Infectious Diseases 2012;44(8):600-4. 3248637
25. Lai CC, Hsu HL, Lee LN, Hsueh PR. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis. Journal of Microbiology, Immunology, and Infection 2007;40(2):148-53. 3248639
26. Liu SJ, Wang X, Wang XH, Zhou H, Yuan D, Jiang H. Quantitative PCR for early diagnosis of invasive fungal infections in patients with hematologic malignancies. Journal of Experimental Hematology/Chinese Association of Pathophysiology 2012;20(5):1225-30. 3248641
27. Machetti M, Feasi M, Mordini N, Van Lint MT, Bacigalupo A, Latge JP, et al. Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplantation 1998;21(9):917-21. 3248643
28. Maertens J, Van Eldere J, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. Journal of Infectious Diseases 2002;186(9):1297-306. 3248645
29. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenaemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. Journal of Infectious Diseases 2004;190(3):641-9. 3248647
30. Moragues MD, Amutio E, Garcia-Ruiz JC, Ponton J. Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis [Utilidad de la deteccion de galactomanano en el diagnostico y seguimiento de la aspergilosis invasora en pacientes hematologicos]. Revista Iberoamericana de Micologia 2003;20(3):103-10. 3248649
31. Nihtinen A, Anttila VJ, Richardson M, Ruutu T, Juvonen E, Meri T, et al. Invasive aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testing. Bone Marrow Transplant 2010;45(2):333-8. 3248651
32. Park SY, Lee S-O, Choi S-H, Sung H, Kim M-N, Choi C-M, et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. Journal of Infection 2010;61(6):492-8. 3248653
33. Pinel C, Fricker-Hidalgo H, Lebeau B, Garban F, Hamidfar R, Ambroise-Thomas P, et al. Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis. Journal of Clinical Microbiology 2003;41(5):2184-6. 3248655
34. Rovira M, Jimenez M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M, et al. Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study. Transplantation 2004;77(8):1260-4. 3248657
35. Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005;37(3):246-53. 3248659
36. Shi Y, Liu DW, Long Y, Liu Y, Rui X, Zhou X, et al. The role of galactomannan detection in the diagnosis of invasive pulmonary aspergillosis in critically ill patients. Zhonghua Nei Ke Za Zhi 2009;48:225-30. 3248661
37. Suankratay C, Kanitcharaskul P, Arunyingmongkol K. Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders. Journal of the Medical Association of Thailand 2006;89(11):1851-8. 3248663
38. Suarez F, Lortholary O, Buland S, Rubio MT, Ghez D, Mahe V, et al. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance. Journal of Clinical Microbiology 2008;46:3772-7. 3248665
39. Sun Q-X, Meng F-Y, Tan X-J, Li J-T, Cai Y-X, Zhu Z-G. Utility of serum galactomannan in diagnosis of invasive fungal infection in hematologic malignancy [Chinese]. Chinese Journal of Infection and Chemotherapy 2009;9(2):140-2. 3248667
40. Sun YQ, Ji Y, Xu LP, Liu DH, Liu KY, Huang XJ. Combination of real-time polymerase chain reaction assay and serum galactomannan in the diagnosis of invasive aspergillosis in patients with hematological malignancies and recipients of hematopoietic stem cell transplantation. Zhonghua Yi Xue Za Zhi 2010;90(6):375-8. 3248669
41. Tabarsi P, Soraghi A, Marjani M, Zandian P, Baghaei P, Najafizadeh K, et al. Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients. Experimental and Clinical Transplantation 2012;10(3):278-81. 3248671
42. Tanase AD, Colita A, Marculescu A, Berteanu C, Streinu Cercel A, Stoica M, et al. Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation. Romanian Journal of Morphology and Embryology 2012;53(2):379-82. 3248673
43. Tanriover MD, Ascioglu S, Altun B, Uzun O. Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance. Mycoses 2010;53(1):16-25. 3248675
44. Ulusakarya A, Chachaty E, Vantelon JM, Youssef A, Tancrede C, Pico JL, et al. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematology Journal 2000;1(2):111-6. 3248677
45. Weisser M, Rausch C, Droll A, Simcock M, Sendi P, Steffen I, et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clinical Infectious Diseases 2005;41(8):1143-9. 3248679
46. White PL, Archer AE, Barnes RA. Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections. Journal of Clinical Microbiology 2005;43(5):2181-7. 3248681
47. White PL, Jones T, Whittle K, Watkins J, Barnes RA. Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples. Clinical and Vaccine Immunology 2013;20(4):636-8. 3248683
48. Williamson EC, Oliver DA, Johnson EM, Foot AB, Marks DI, Warnock DW. Aspergillus antigen testing in bone marrow transplant recipients. Journal of Clinical Pathology 2000;53(5):362-6. 3248685
49. Xie LP, Liu T, Meng WT, Zhou J. The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients. Zhonghua Nei Ke Za Zhi 2006;45(12):992-5. 3248687
50. Xu J, Sun ZM, Wang XB, Zhang XH. Early antigen diagnosis of invasive fungal infection in patients with hematological malignancies and patients receiving hematopoietic stem cell transplantation. Zhongguo Shi Yan.Xue Ye Xue Za Zhi 2010;18(5):1302-5. 3248689
51. Xu M-Z, Sun A-N, Wu D-P, Qiu H-Y, Tang X-W, Fu Z-Z, et al. Utility of serum galactomannan antigen for diagnosis and follow-up of invasive aspergillosis in hematological patients [Chinese]. Chinese Journal of Infection and Chemotherapy 2009;9(3):233-6. 3248691
52. Xu PF, Zhou JY, Zhou H, Shen P. Serum antigens assay combined with chest CT scan in diagnosis of invasive pulmonary aspergillosis. Journal of Zhejiang University Medical Sciences 2012;41(3):332-8. 3248693
53. Yoo JH, Choi JH, Choi SM, Lee DG, Shin WS, Min WS, et al. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases. Clinical Infectious Diseases 2005;40(3):392-8. 3248695
54. Zhang XY, Zhao SY, Jiang ZF. Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis. Zhonghua Er Ke Za Zhi 2009;47(2):83-6. 3248697
55. Acosta J, Catalan M, Del Palacio-Perez-Medel A, Lora D, Montejo JC, Cuetara MS, et al. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1--> 3) -beta-d-glucan chromogenic assay in serum samples. Clinical Microbiology and Infection 2011;17(7):1053-60. 3248699
56. Acosta J, Catalan M, Del Palacio-Perez-Medel A, Lora D, Montejo J-C, Cuetara M-S, et al. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: Comparison with the diagnostic performance of galactomannan and of (1-> 3) -beta-d-glucan chromogenic assay in serum samples. Clinical Microbiology and Infection 2011;17(7):1053-60. 3248701
57. Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. Journal of Antimicrobial Chemotherapy 2008;61(2):411-6. 3248703
58. Bellanger AP, Grenouillet F, Henon T, Skana F, Legrand F, Deconinck E, et al. Retrospective assessment of beta-D-(1, 3)-glucan for presumptive diagnosis of fungal infections. APMIS 2011;119(4-5):280-6. 3248705
59. Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010;137(2):410-5. 3248707
60. Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. Journal of Clinical Microbiology 2012;50(3):823-30. 3248709
61. Bochenek M, Rup E, Macura AB. Mycoserological tests in the diagnosis of invasive aspergillosis [Polish]. Mikologia Lekarska 2007;14(3):174-8. 3248711
62. Bretagne S, Marmorat-Khuong A, Kuentz M, Latge JP, Bart-Delabesse E, Cordonnier C. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. Journal of Infection 1997;35(1):7-15. 3248713
63. Castagnola E, Furfaro E, Caviglia I, Licciardello M, Faraci M, Fioredda F, et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clinical Microbiology and Infection 2010;16(8):1197-203. 3248715
64. Cesaro S, Stenghele C, Calore E, Franchin E, Cerbaro I, Cusinato R, et al. Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses 2008;51(6):497-504. 3248717
65. Challier S, Boyer S, Abachin E, Berche P. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. Journal of Clinical Microbiology 2004;42(2):844-6. 3248719
66. Cuenca-Estrella M, Meije Y, Diaz-Pedroche C, Gomez-Lopez A, Buitrago MJ, Bernal-Martinez L, et al. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia. Journal of Clinical Microbiology 2009;47(2):379-84. 3248721
67. Desai R, Ross LA, Hoffman JA. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatric Infectious Disease Journal 2009;28(4):283-6. 3248723
68. Fortun J, Martin-Davila P, Alvarez ME, Sanchez-Sousa A, Quereda C, Navas E, et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001;71(1):145-9. 3248725
69. Fujiuchi S, Yamamoto Y, Takeda A, Nishigaki Y, Fujit Y, Yamazaki Y, et al. Evaluation of galactomannan antigen and beta-D-glucan value for diagnosis of chronic necrotizing pulmonary aspergillosis. Nihon Kokyuki Gakkai Zasshi 2009;47(1):7-11. 3248727
70. Guinea J, Jensen J, Pelaez T, Gijon P, Alonso R, Rivera M, et al. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Medical Mycology 2008;46(6):575-9. 3248729
71. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1, 3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. Journal of Clinical Microbiology 2009;47(1):129-33. 3248731
72. Hadrich I, Mary C, Makni F, Elloumi M, Dumon H, Ayadi A, et al. Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies. Medical Mycology 2011;49(5):489-94. 3248733
73. Hayden R, Pounds S, Knapp K, Petraitiene R, Schaufele RL, Sein T, et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatric Infectious Disease Journal 2008;27(9):815-9. 3248735
74. He H, Ding L, Chang S, Li F, Zhan Q. Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease. Medical Mycology 2011;49(4):345-51. 3248737
75. Hu H, Yang Y, Teng GL, Ju YF, Zhang LL, Wei M. Application of detecting bronchoalveolar lavage fluid Aspergillus galactomannan antigen in the diagnosis of pulmonary aspergillosis. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal] 2012;92(32):2268-70. 3248739
76. Husain S, Kwak EJ, Obman A, Wagener MM, Kusne S, Stout JE, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. American Journal of Transplantation 2004;4(5):796-802. 3248741
77. Jarque I, Andreu R, Salavert M, Gomez D, Peman J, Gobernado M, et al. Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients. Revista Iberoamericana de Micología 2003;20(3):116-8. 3248743
78. Jathavedam A, Dure DC, Taur Y, Weinstock DM. Limited utility of serum galactomannan assay after auto-SCT. Bone Marrow Transplant 2009;44(1):59-61. 3248745
79. Ji Y, Liu DH, Xu LP, Liu KY, Huang XJ. The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients. Zhonghua Xue Ye Xue Za Zhi 2007;28(2):83-6. 3248747
80. Ji Y, Xu LP, Liu DH, Chen YH, Han W, Zhang XH, et al. Positive results of serum galactomannan assays and pulmonary computed tomography predict the higher response rate of empirical antifungal therapy in patients undergoing allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2011;17(5):759-64. 3248749
81. Jin, J.Sun, T.Y.Hu, Y.J.Li, Y.M. Multiple serum antigenic assays for diagnosis of invasive fungal infections in non-neutropenic adult patients. Chinese journal of tuberculosis and respiratory diseases 2010;33(9):not reported. 3248751
82. Khanna S, Oberoi JK, Datta S, Aggarwal S, Wattal C. Variables affecting the performance of galactomannan assay in high-risk patients at a tertiary care centre in India. Indian Journal of Medical Microbiology 2013;31(1):34-9. 3248753
83. Kimura S, Odawara J, Aoki T, Yamakura M, Takeuchi M, Matsue K. Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. International Journal of Hematology 2009;90(4):463-70. 3248755
84. Kitasato Y, Tao Y, Hoshino T, Tachibana K, Inoshima N, Yoshida M, et al. Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 2009;14(5):701-8. 3248757
85. Leng Y, Li LH. Feasibility of serum galactomannan assay in hematologic malignancy patients with invasive fungal infections. Journal of Leukemia and Lymphoma 2010;19(7):551-2. 3248759
86. Li LL, Wang JM, Zhang WP, Hou J, Cheng H, Yang JM, et al. Value of circulating galactomannan screening for early diagnosis of invasive aspergillosis in hematological patients. Journal of Leukemia and Lymphoma 2011;20(7):418-21. 3248761
87. Lim ZY, Pagliuca A, Wade J, Ho A, Devereux S, Mufti GJ. Use of the galactomannan ELISA in the detection of invasive aspergillosis: a retrospective review and potential pitfalls in application. British Journal of Haematology 2004;125:59-60. 3248763
88. Lopes da Silva R, Ribeiro P, Abreu N, Ferreira T, Fernandes T, Monteiro A, et al. Early diagnosis of invasive aspergillosis in neutropenic patients. Comparison between serum galactomannan and polymerase chain reaction. Clinical Medicine Insights. Oncology 2010;4:81-8. 3248765
89. Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, et al. Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients. British Journal of Haematology 2004;126(6):852-60. 3248767
90. Maertens JA, Klont R, Masson C, Theunissen K, Meersseman W, Lagrou K, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clinical Infectious Diseases 2007;44(10):1329-36. 3248769
91. Maertens J, Theunissen K, Lodewyck T, Lagrou K, Van Eldere J. Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders. Mycoses 2007;50 Suppl 1:2-17. 3248771
92. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clinical Infectious Diseases 2005;40(12):15. 3248773
93. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. American Journal of Respiratory and Critical Care Medicine 2008;177(1):27-34. 3248775
94. Pazos C, Ponton J, del Palacio A. Contribution of (1 -> 3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. Journal of Clinical Microbiology 2005;43(1):299-305. 3248777
95. Penack O, Rempf P, Graf B, Blau IW, Thiel E. Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management. Annals of Oncology 2008;19(5):984-9. 3248779
96. Pereira CN, Del Nero G, Lacaz CS, Machado CM. The contribution of galactomannan detection in the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Mycopathologia 2005;159(4):487-93. 3248781
97. Perkins JD. Use of Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) in liver transplant patients. Liver Transplantation 2007;13(2):304-5. 3248783
98. Racil Z, Kocmanova I, Wagnerova B, Winterova J, Lengerova M, Moulis M, et al. The use of galactomannan detection in diagnosing invasive aspergillosis in hemato-oncological patients. Vnitrni Lekarstvi 2008;54(1):45-52. 3248785
99. Rogers TR, Morton CO, Springer J, Conneally E, Heinz W, Kenny C, et al. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies. British Journal of Haematology 2013;161(4):517-24. 3248787
100. Sarrafzadeh SA, Hoseinpoor Rafati A, Ardalan M, Mansouri D, Tabarsi P, Pourpak Z. The accuracy of serum galactomannan assay in diagnosing invasive pulmonary aspergillosis. Iranian Journal of Allergy, Asthma, and Immunology 2010;9(3):149-55. 3248789
101. Steinbach WJ, Addison RM, McLaughlin L, Gerrald Q, Martin PL, Driscoll T, et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatric Infectious Disease Journal 2007;26(7):558-64. 3248791
102. Sulahian A, Tabouret M, Ribaud P, Sarfati J, Gluckman E, Latge JP, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. European Journal of Clinical Microbiology and Infectious Diseases 1996;15(2):139-45. 3248793
103. Sulahian A, Boutboul F, Ribaud P, Leblanc T, Lacroix C, Derouin F. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001;91(2):311-8. 3248795
104. Tabone MD, Vu-Thien H, Latge JP, Landman-Parker J, Perez-Castiglioni P, Moissenet D, et al. Value of galactomannan detection by sandwich enzyme-linked immunosorbent assay in the early diagnosis and follow-up of invasive aspergillosis. Opportunistic Pathogens 1997;9(1):5-15. 3248797
105. Uryu H, Kozeki M, Asada N, Takeuchi M, Suenaga T. Analysis of serum Aspergillus galactomannan contents conducted at our hospital during the past 2 years. Japanese Journal of Antibiotics 2006;59(5):413-4. 3248799
106. Verweij PE, Latge JP, Rijs AJ, Melchers WJ, de Pauw BE, Hoogkamp-Korstanje JA, et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. Journal of Clinical Microbiology 1995;33(12):3150-3. 3248801
107. Wang Y Y, Xiao CL, Li JM, Zhao WL, Mi JQ, Hu J, Ni YX, Shen ZX. The retrospective study of serum aspergillus galactomannan (GM) antigen assay in invasive aspergillosis on hematological diseases. Chung-Hua Hsueh Yeh Hsueh Tsa Chih [Chinese Journal of Hematology] 2013;34(6):498-501. 3248803
108. Xiang J, Sun Z, Xu Z, Xia J, Huan J. Contribution of galactomannan antigen assay to early diagnosis of aspergillosis in patients with extensive burns. Chinese Journal of Infection and Chemotherapy 2010;10(4):304-7. 3248805
109. Yao JF, Su D, Huang Y, Zhang P, Lin QS, Wang ZY, et al. A preliminary investigation on early diagnosis of invasive aspergillusis in patients with blood diseases by using circulating galactomannan test. Zhongguo Shi Yan.Xue Ye Xue Za Zhi 2009;17(3):765-9. 3248807
110. Yu J, Li RY, Gao LJ, Lu QY, Wang XH. Utility of galactomannan enzyme immunoassay and (1, 3)beta-D-glucan assay in invasive fungal infection. Zhonghua Yi Xue Za Zhi 2010;90(6):371-4. 3248809
111. Zedek DC, Miller MB. Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period. Journal of Clinical Microbiology 2006;44(4):1601. 3248811
112. Zeng SY, Liu T, Meng WT, Chen YN. The significance of serum GM and BG antigens assay for invasive fungal infections in hematological malignancies patients. Zhonghua Xue Ye Xue Za Zhi 2011;32(1):43-6. 3248813
113. Ascioglu S, de Pauw BE, Donnelly JP, Collette L. Reliability of clinical research on invasive fungal infections: a systematic review of the literature. Medical Mycology 2001;39(1):35-40.
114. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Diseases 2002;34(1):7-14.
115. Borlenghi E, Cattaneo C, Capucci MA, Pan A, Quaresmini G, Franco F, et al. Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates. Annals of Hematology 2007;86(3):205-10.
116. Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD009551.pub3]
117. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical infectious Diseases 2008;46(12):1813-21. [DOI: 10.1086/588660; PUBMED: 18462102]
118. Denning DW, Marinus A, Cohen J, Spence D, Herbrecht R, Pagano L, et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. Journal of Infection 1998;37(2):173-80.
119. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infectious Diseases 2005;5(2):609-22.
120. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282(11):1054-60.
121. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. European Journal of Clinical Microbiology and Infectious Diseases 2002;21(3):161-72.
122. Latgé JP, Kobayashi H, Debeaupuis JP, Diaquin M, Sarfati J, Wieruszeski JM, et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infection and Immunity 1994;62(6):5424-33.
123. Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Bossuyt PM. Meta-analysis of diagnostic test accuracy. Clinical Infectious Diseases 2006;43(9):1220.
124. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases 2002;34(7):909-17.
125. Mennink-Kersten MASH, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infectious Diseases 2004;4(6):349-57.
126. Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Annals of Internal Medicine 2002;137:598-602.
127. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clinical Infectious Diseases 2006;42(10):1417-27.
128. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982-90.
129. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. American Journal of Respiratory and Critical Care Medicine 2006;173(7):707-17.
130. Singh N. Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management. Medical Mycology 2005;43 Suppl 1:S267-70.
131. Subira M, Martino R, Rovira M, Vazquez L, Serrano D, De La Camara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Annals of Hematology 2003;82(2):80-2.
132. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clinical Infectious Diseases 2007;44(4):531-40.
133. Verdaguer V, Walsh TJ, Hope W, Cortez KJ. Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Review of Molecular Diagnostics 2007;7(1):21-32.
134. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 2003;3:25.
135. Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Medical Research Methodology 2005;5:19.
136. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529-36. [PUBMED: 22007046]